首页> 外文期刊>Breast Cancer Research and Treatment >Differential Expression of the Early Lung Cancer Detection Marker, Heterogeneous Nuclear Ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in Normal Breast and Neoplastic Breast Cancer
【24h】

Differential Expression of the Early Lung Cancer Detection Marker, Heterogeneous Nuclear Ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in Normal Breast and Neoplastic Breast Cancer

机译:正常乳腺癌和赘生性乳腺癌中早期肺癌检测标记物,异种核糖核蛋白-A2 / B1(hnRNP-A2 / B1)的差异表达

获取原文
获取原文并翻译 | 示例
       

摘要

Heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP-A2/B1) is highly expressed during critical stages of lung development and carcinogenesis. To determine if the expression of hnRNP-A2/B1 is an informative biomarker in breast carcinogenesis, we analyzed hnRNP-A2/B1 overexpression by immunohistochemistry in archived specimens. Expression was detected in 48/85 (56.5%) primary invasive breast cancers and 7/72 (9.7%) specimens of normal breast tissue. Northern analysis of breast cancer cells also demonstrated higher level of hnRNP-A2/B1 expression compared to normal or transformed breast cells. Expression of hnRNP-A2/B1 in breast cancer cells was decreased by exposure to retinoids coordinately with decreased cell growth. These results warrant further evaluation of hnRNP-A2/B1 as a marker of breast carcinogenesis.
机译:异质核糖核蛋白A2 / B1(hnRNP-A2 / B1)在肺发育和癌变的关键阶段高表达。为了确定hnRNP-A2 / B1的表达是否是乳腺癌发生的信息学标志,我们通过免疫组织化学分析了存档标本中hnRNP-A2 / B1的过度表达。在48/85(56.5%)原发性浸润性乳腺癌和7/72(9.7%)正常乳腺组织标本中检测到表达。与正常或转化的乳腺癌细胞相比,乳腺癌细胞的Northern分析还显示出更高水平的hnRNP-A2 / B1表达。乳腺癌细胞中hnRNP-A2 / B1的表达通过与类维生素A的接触与细胞生长的降低相协调而降低。这些结果需要进一步评估hnRNP-A2 / B1作为乳腺癌发生的标志。

著录项

  • 来源
    《Breast Cancer Research and Treatment》 |2001年第3期|217-224|共8页
  • 作者单位

    Intervention Section Department of Cell and Cancer Biology Medicine Branch Division of Clinical Sciences National Cancer Institute National Institutes of HealthCurrent address: H. Lee Moffitt Cancer Center University of South Florida;

    Baylor College of Medicine Breast Center;

    Intervention Section Department of Cell and Cancer Biology Medicine Branch Division of Clinical Sciences National Cancer Institute National Institutes of Health;

    Intervention Section Department of Cell and Cancer Biology Medicine Branch Division of Clinical Sciences National Cancer Institute National Institutes of Health;

    Intervention Section Department of Cell and Cancer Biology Medicine Branch Division of Clinical Sciences National Cancer Institute National Institutes of Health;

    Intervention Section Department of Cell and Cancer Biology Medicine Branch Division of Clinical Sciences National Cancer Institute National Institutes of Health;

    Intervention Section Department of Cell and Cancer Biology Medicine Branch Division of Clinical Sciences National Cancer Institute National Institutes of Health;

    Intervention Section Department of Cell and Cancer Biology Medicine Branch Division of Clinical Sciences National Cancer Institute National Institutes of Health;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    breast carcinogenesis; early detection marker; immunohistochemistry; intermediate endpoint marker;

    机译:乳腺癌变;早期检测标志物;免疫组化;中间终点标志物;
  • 入库时间 2022-08-18 02:11:16

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号